| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.07B | 19.38B | 18.18B | 16.79B | 12.59B | 10.91B |
| Gross Profit | 9.50B | 6.95B | 6.50B | 6.13B | 4.70B | 4.17B |
| EBITDA | 4.05B | 3.92B | 3.79B | 3.81B | 2.92B | 2.79B |
| Net Income | 968.00M | 893.00M | 1.08B | 1.12B | 830.00M | 941.00M |
Balance Sheet | ||||||
| Total Assets | 29.32B | 27.08B | 24.75B | 24.47B | 23.05B | 19.34B |
| Cash, Cash Equivalents and Short-Term Investments | 2.79B | 2.26B | 2.24B | 2.33B | 1.94B | 1.39B |
| Total Debt | 16.23B | 13.47B | 12.03B | 11.64B | 11.35B | 9.29B |
| Total Liabilities | 20.89B | 18.08B | 16.27B | 15.78B | 15.14B | 12.40B |
| Stockholders Equity | 8.43B | 9.00B | 8.47B | 8.69B | 7.91B | 6.94B |
Cash Flow | ||||||
| Free Cash Flow | 2.81B | 2.47B | 2.75B | 2.18B | 1.98B | 1.87B |
| Operating Cash Flow | 3.25B | 2.88B | 3.41B | 2.71B | 2.28B | 2.20B |
| Investing Cash Flow | -1.26B | -1.24B | -700.00M | -637.00M | -693.00M | -426.00M |
| Financing Cash Flow | -1.23B | -1.61B | -2.79B | -1.70B | -1.05B | -1.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥3.40B | 3.11 | ― | 1.24% | 6.77% | 40.10% | |
68 Neutral | ¥30.58B | 5.63 | 21.87% | 2.14% | 15.35% | 45.10% | |
66 Neutral | ¥19.42B | 14.99 | ― | 5.16% | 6.58% | ― | |
66 Neutral | ¥27.87B | 34.20 | 21.68% | 1.02% | 14.02% | 32.73% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥32.76B | 5.66 | ― | 2.48% | -4.39% | 31.40% | |
47 Neutral | ¥2.59B | 11.92 | ― | ― | -6.45% | 99.39% |